We are live on ! Find out more
ACIU icon

AC Immune
ACIU

37 hedge funds and large institutions have $85.7M invested in AC Immune in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

81% more call options, than puts

Call options by funds: $292K | Put options by funds: $161K

71% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 7

16% more funds holding

Funds holding: 32 → 37 (+5)

2.6% less ownership

Funds ownership: 31.79% → 29.2% (-2.6%)

45% less capital invested

Capital invested by funds: $157M → $85.7M (-$71.2M)

Holders
37
Holders Change
+5
Holders Change %
+15.63%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
12
Reduced
7
Closed
5
Calls
$292K
Puts
$161K
Net Calls
+$131K
Net Calls Change
-$33K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$444K
2
LCM
Landscape Capital Management
New Jersey
+$421K
3
Renaissance Technologies
Renaissance Technologies
New York
+$352K
4
SM
Scoggin Management
New York
+$303K
5
Citadel Advisors
Citadel Advisors
Florida
+$218K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$7.64M
2
SC
Stempoint Capital
New York
-$2.17M
3
PIM
Platinum Investment Management
Australia
-$1.51M
4
Wells Fargo
Wells Fargo
California
-$104K
5
UBS Group
UBS Group
Switzerland
-$76.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
26
BNP Paribas Financial Markets
France
$32.8K +$30.2K +8,423 +316%
Lazard Asset Management
27
Lazard Asset Management
New York
$30K +$36.8K +10,260 New
CLOS
28
Compagnie Lombard Odier SCmA
Switzerland
$29.6K – – –
TRCT
29
Tower Research Capital (TRC)
New York
$17.3K +$18.1K +5,052 +649%
Zurich Cantonal Bank
30
Zurich Cantonal Bank
Switzerland
$11.6K +$14K +3,919 New
Bank of America
31
Bank of America
North Carolina
$8.63K +$9.52K +2,656 +1,029%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$6K -$41K -11,437 -85%
Group One Trading
33
Group One Trading
Illinois
$1.33K +$1.62K +451 New
SFCL
34
Strengthening Families & Communities LLC
Massachusetts
$1K – – –
Simplex Trading
35
Simplex Trading
Illinois
$1K +$2.28K +635 New
Citigroup
36
Citigroup
New York
$918 -$4.32K -1,204 -80%
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
$142 +$172 +48 New
SC
38
Stempoint Capital
New York
– -$2.17M -434,588 Closed
NPT
39
Nixon Peabody Trust
Massachusetts
– -$64.3K -12,850 Closed
VF
40
Virtu Financial
New York
– -$58K -11,552 Closed
EDRH
41
Edmond de Rothschild Holding
Switzerland
– -$10K -2,000 Closed
Osaic Holdings
42
Osaic Holdings
Arizona
– -$10K -2,000 Closed
1
2

ACIU Hedge Fund Activity: Q1 2024 in Review

37 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2024, worth a combined $85.7M — down 45% from $157M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ACIU positions and 5 closed out — a net gain of 5 holders — while 12 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, adding an estimated $444K. The largest seller was Morgan Stanley, cutting an estimated $7.64M.

  • 37 institutional investors held AC Immune (ACIU) as of Q1 2024, up from 32 in Q4 2023.
  • Funds reported $85.7M of AC Immune stock for Q1 2024, down 45% quarter-over-quarter.
  • 10 funds opened new AC Immune positions in Q1 2024 and 5 closed out, a net change of +5 holders.
  • The largest AC Immune buyer in Q1 2024 was BlackRock, an estimated $444K added.
  • The largest AC Immune seller in Q1 2024 was Morgan Stanley, an estimated $7.64M sold.

Based on aggregated 13F filings for Q1 2024.